These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11688312)

  • 1. Sudden cardiac death in hypertrophic cardiomyopathy.
    Malanuk RM; Nielsen CD; Spencer WH
    J S C Med Assoc; 2001 Oct; 97(10):424-7. PubMed ID: 11688312
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2010 Jan; 121(3):445-56. PubMed ID: 20100987
    [No Abstract]   [Full Text] [Related]  

  • 3. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
    Maron BJ
    Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
    [No Abstract]   [Full Text] [Related]  

  • 4. Sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott P; McKenna W
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):443-51. PubMed ID: 23022709
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden cardiac death risk in hypertrophic cardiomyopathy.
    Ommen SR; Gersh BJ
    Eur Heart J; 2009 Nov; 30(21):2558-9. PubMed ID: 19706724
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessment in hypertrophic cardiomyopathy.
    Ward D
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218266
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk assessment in hypertrophic cardiomyopathy.
    Saumarez RC
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218265
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA; Gomes JA; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
    Spirito P; Autore C; Rapezzi C; Bernabò P; Badagliacca R; Maron MS; Bongioanni S; Coccolo F; Estes NA; Barillà CS; Biagini E; Quarta G; Conte MR; Bruzzi P; Maron BJ
    Circulation; 2009 Apr; 119(13):1703-10. PubMed ID: 19307481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The science of uncertainty and the art of probability: syncope and its consequences in hypertrophic cardiomyopathy.
    Elliott P; McKenna W
    Circulation; 2009 Apr; 119(13):1697-9. PubMed ID: 19349332
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death in athletes.
    Tripathi BK; Gupta B; Agarwal AK
    J Assoc Physicians India; 2001 Jun; 49():643-9. PubMed ID: 11584942
    [No Abstract]   [Full Text] [Related]  

  • 15. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.
    Ostman-Smith I; Wettrell G; Keeton B; Holmgren D; Ergander U; Gould S; Bowker C; Verdicchio M
    Eur Heart J; 2008 May; 29(9):1160-7. PubMed ID: 18385119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy. Sudden death is rare in young people with hypertrophic cardiomyopathy.
    Wald DS; Law M
    BMJ; 2006 Jul; 333(7558):96-7; author reply 97. PubMed ID: 16825235
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED
    J Am Coll Cardiol; 2009 Dec; 55(1):77. PubMed ID: 20117370
    [No Abstract]   [Full Text] [Related]  

  • 20. The quest for perfection: the contribution of the electrocardiogram to the prevention of sudden death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott P
    Europace; 2009 May; 11(5):548-9. PubMed ID: 19287015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.